MYRIAD GENETICS INC
Customers
1
1 active
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Dec 31, 2025
10-K filed 2026-02-24
Customers 1
Companies MYGN discloses as major customers, as a share of MYGN revenue. 1 active, 0 lapsed.
| Company | % of MYGN revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| Medicare Non-SEC Medicare |
Named | — | FY 2025-12-31 | — | Active | 10-K 2026-02-24 |
Revenues received from Medicare represented approximately 13%, 12%, and 12% of total revenue for the years ended December 31, 2025, 2024, and 2023, respectively. The federal Civil Monetary Penalties Law (the CMP Law), prohibits, among other things, (1) the offering or transfer of remuneration to a Medicare or state health care program beneficiary if the person knows or should know it is likely to influence the beneficiary’s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program, unless an exception applies; | ||||||
Alerts are coming
Get an email when MYGN's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.